Business Context and Reporting Period
This Form 8-K was filed by Inpixon (trading symbol: INPX) on November 5, 2019. The filing reports the entry into a material definitive agreement involving the exchange of debt for equity. Note: The request metadata references "XTI Aerospace, Inc.", but the filing text explicitly identifies the registrant as "Inpixon".
Key Financial Metrics and Transaction Details
- Debt Converted: $202,400 (partitioned from an Original Note with a total outstanding balance of $1,486,823.60).
- Equity Issued: 2,300,000 shares of Common Stock.
- Effective Price: $0.088 per share.
- Counterparty: Iliad Research and Trading, L.P. (holder of the Original Note).
- Other Outstanding Debt (as of Oct 27, 2019):
- Additional note held by Iliad: ~$963,000.
- Notes held by Chicago Venture Partners, L.P. (affiliate of Iliad): ~$9.8 million.
- Total Outstanding Shares (post-transaction): 71,129,378 shares of Common Stock.
Material Changes Versus Prior Period
The filing does not provide comparative financial statements (revenue, profit, or cash flow) for the period. The primary material change is the reduction of debt obligations by $202,400 and a corresponding increase in outstanding common shares by 2,300,000. The filing text does not provide a clear value for the company's total debt or liquidity position beyond the specific notes mentioned.
Guidance, Outlook, and Risks
- Transaction Status: The exchange was executed on November 5, 2019, with shares delivered to Iliad upon approval by their brokerage firm for public resale.
- Regulatory Exemption: The issuance was unregistered, relying on Section 3(a)(9) of the Securities Act of 1933 as an exchange of securities without additional consideration or commissions.
- Capital Structure: The company holds various convertible preferred stock and warrants (Series 4, Series 5, and Series A warrants) which may impact future share counts.
- Outlook: No forward-looking guidance or management commentary regarding future revenue or operations is included in this filing.
Key Facts for Investor Verification
- Verify the total outstanding debt load, noting that ~$9.8 million in notes held by an affiliate of the counterparty remains outstanding.
- Confirm the dilution impact of the 2,300,000 new shares relative to the pre-transaction share count.
- Review the terms of the remaining $963,000 note held by Iliad and the $9.8 million held by Chicago Venture Partners to assess future refinancing or conversion risks.
- Check the exercise prices and expiration dates of the outstanding warrants (Series A at $0.2775 and Rights Offering warrants at $3.33) to evaluate potential future dilution.